LIFETECH SCI.DL-00000125 (81X) - Total Assets
Based on the latest financial reports, LIFETECH SCI.DL-00000125 (81X) holds total assets worth €5.01 Billion EUR (≈ $5.86 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 81X operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
LIFETECH SCI.DL-00000125 - Total Assets Trend (2021–2025)
This chart illustrates how LIFETECH SCI.DL-00000125's total assets have evolved over time, based on quarterly financial data. See 81X net asset value for net asset value and shareholders' equity analysis.
LIFETECH SCI.DL-00000125 - Asset Composition Analysis
Current Asset Composition (December 2025)
LIFETECH SCI.DL-00000125's total assets of €5.01 Billion consist of 46.4% current assets and 53.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 14.4% |
| Accounts Receivable | €161.80 Million | 3.2% |
| Inventory | €444.90 Million | 8.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €779.18 Million | 15.6% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how LIFETECH SCI.DL-00000125's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see LIFETECH SCI.DL-00000125 stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: LIFETECH SCI.DL-00000125's current assets represent 46.4% of total assets in 2025, a decrease from 57.7% in 2021.
- Cash Position: Cash and equivalents constituted 14.4% of total assets in 2025, down from 35.2% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 11.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 15.6% of total assets.
LIFETECH SCI.DL-00000125 Competitors by Total Assets
Key competitors of LIFETECH SCI.DL-00000125 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
LIFETECH SCI.DL-00000125 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.57 | 2.86 | 2.68 |
| Quick Ratio | 1.27 | 2.21 | 2.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €845.73 Million | €1.52 Billion | €1.39 Billion |
LIFETECH SCI.DL-00000125 - Advanced Valuation Insights
This section examines the relationship between LIFETECH SCI.DL-00000125's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.02 |
| Latest Market Cap to Assets Ratio | 0.15 |
| Asset Growth Rate (YoY) | 2.3% |
| Total Assets | €5.01 Billion |
| Market Capitalization | $766.60 Million USD |
Valuation Analysis
Below Book Valuation: The market values LIFETECH SCI.DL-00000125's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: LIFETECH SCI.DL-00000125's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for LIFETECH SCI.DL-00000125 (2021–2025)
The table below shows the annual total assets of LIFETECH SCI.DL-00000125 from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €5.01 Billion ≈ $5.86 Billion |
+2.29% |
| 2024-12-31 | €4.90 Billion ≈ $5.73 Billion |
+4.34% |
| 2023-12-31 | €4.70 Billion ≈ $5.49 Billion |
+27.27% |
| 2022-12-31 | €3.69 Billion ≈ $4.31 Billion |
+15.91% |
| 2021-12-31 | €3.18 Billion ≈ $3.72 Billion |
-- |
About LIFETECH SCI.DL-00000125
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac P… Read more